The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

Eun Ju LeeDepartment of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea;

Ha Nee JangDepartment of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea;

Hyun Seop ChoDepartment of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea;

Eunjin BaeDepartment of Internal Medicine, Changwon Gyeongsang National University Hospital, Changwon, South Korea;

Tae Won LeeDepartment of Internal Medicine, Changwon Gyeongsang National University Hospital, Changwon, South Korea;

Se-Ho ChangDepartment of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea; ;Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, South Korea; ;Institute of Health Science, Gyeongsang National University, Jinju, South Korea

Dong Jun ParkDepartment of Internal Medicine, Changwon Gyeongsang National University Hospital, Changwon, South Korea; ;Department of Internal Medicine, College of Medicine, Gyeongsang National University, Jinju, South Korea; ;Institute of Health Science, Gyeongsang National University, Jinju, South KoreaCorrespondence[email protected]

show all

The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date